Professor Hemant Kocher

Professor Kocher’s project will investigate why immunotherapy - a treatment which harnesses the patient’s immune system to kill cancer cells - doesn't work with pancreatic cancer.

Grant made in 2018 Award Round

Principal Applicant: Professor Hemant Kocher

Research Institution: Barts Cancer Institute, Queen Mary University of London

Award: £200,000

Duration: 3 years

Back to listing

Project title: The role of T-cells within tertiary lymphoid structures
of pancreatic ductal adenocarcinoma

Project aims: Professor Kocher’s project will investigate why immunotherapy – a treatment which harnesses the patient’s immune system to kill cancer cells – works with some cancers but not with pancreatic cancer.The team will investigate how immune cells interact with each other and are either triggered or dampened in pancreatic cancer. The aim of this project is to determine the most effective way of combining immunotherapy and chemotherapy in future pancreatic cancer clinical trials.